It is administered as a once-weekly subcutaneous injection following a structured dose-escalation schedule, typically starting at 2 mg and increasing to 812 mg weekly in Phase 2 protocols
Sin embargo, la fase 2 del ensayo clnico de Retatrutida sobre el impacto en la obesidad, Low Wang indic que el 100% de las personas voluntarias del estudio que recibieron 8 miligramos o ms del medicamento en lugar del placebo perdieron al menos el 5% de su peso corporal
Application Areas
Pinkerton, J
We serve patients from Fayetteville, NC, Hope Mills NC, Spring Lake NC, Cedar Creek NC, Woodbridge NC, Pinehurst NC and surrounding areas, We also offer virtual only visits in select states nationwide
By systematically examining this wide array of disorders, the study sheds light on the potential therapeutic roles of GLP-1RAs beyond their established metabolic applications